ABSTRACT Silk-elastin-like proteins (SELPs) are a family of genetically engineered recombinant protein polymers exhibiting mechanical and biological properties suited for a wide range of

applications in the biomedicine and materials fields. They are being explored as the next generation of biomaterials but low productivities and use of antibiotics during production undermine

their economic viability and safety. We have developed an industrially relevant, scalable, fed-batch process for the high level production of a novel SELP in _E. coli_ in which the commonly

used antibiotic selection marker of the expression vector is exchanged for a post segregational suicide system, the separate-component-stabilisation system (SCS). SCS significantly augments

absence of competing plasmid-free cells improves host cell viability and enables increased productivity with SCS. With the process developed, 12.8 g L−1 purified SELP was obtained, this is

the highest SELP productivity reported to date and clearly demonstrates the commercial viability of these promising polymers. SIMILAR CONTENT BEING VIEWED BY OTHERS ECTOPIC EXPRESSION OF

SERICIN ENABLES EFFICIENT PRODUCTION OF ANCIENT SILK WITH STRUCTURAL CHANGES IN SILKWORM Article Open access 22 October 2022 EXPLORING THE SELF-ASSEMBLY OF SILK PROTEINS THROUGH

LIQUID-LIQUID PHASE SEPARATION Article Open access 28 April 2025 METAL IONS GUIDE THE PRODUCTION OF SILKWORM SILK FIBERS Article Open access 06 August 2024 INTRODUCTION Materials and

biomaterials based on proteins have attracted much attention in recent years due to their unique mechanical and biological properties1,2,3,4 which rival those of synthetic polymers and lend

them to numerous applications in a wide range of areas5,6,7,8,9,10,11. These protein based polymers (PBPs) are expected to substitute synthetic polymers in many applications as they offer

the advantages of being monodisperse, biodegradable, biocompatible and more environmentally friendly1,2,3. Furthermore, the genetically encoded template-based synthesis of these polymers

provides for precise control of their design and the fabrication of novel customised biopolymers tailored for a particular application. Some potential applications include drug delivery,

tissue engineering and as constituents of implanted medical devices, as well as surgical applications such as soft tissue augmentation and bone repair5,6,7,8,9,10,11. Most commonly, PBPs are

inspired by naturally occurring fibrous proteins such as silk, elastin and collagen and make use of the repetitive amino acid sequence motifs characteristic of these proteins and

responsible for their favourable mechanical properties1,2. We have synthesised a number of novel artificial block copolymers combining the repetitive amino acid sequence motifs of silk and

elastin12. These silk-elastin-like proteins (SELPs) combine the crystallinity and mechanical strength of silk with the high resilience and water solubility of elastin in a single structure.

They have been successfully processed into hydrogels, fibers and films and shown to be suitable for application as biomaterials in tissue engineering, namely as wound dressing for skin

regeneration13 and in ophthalmic applications14, but also in general materials science as transparent insulating material for photonics and electronics14. In addition, SELPs are also

promising candidates for use in drug and gene delivery, tissue culture and as biodegradable plastics1,2,15. The widespread application of SELPs and PBPs is currently limited by their low

production levels16,17,18,19,20 and hence high production costs, with the highest SELP productivity reported prior to initiation of our studies being only 85 mg per litre of production

culture20. In an attempt to enhance the commercial viability of these novel polymers we undertook a project aimed at increasing SELP productivity and developing a scalable cost effective

production process for these21,22. Our initial study focused on optimising batch production in the _E. coli_ BL21(DE3)-pET expression system via an in-depth empirical approach comparing all

process variables and enabled an increase in productivity up to 500 mg/L purified SELP21. In addition, factors potentially limiting further improved productivities were identified and

included an accumulation of the metabolic byproduct acetate to toxic levels, plasmid instability of culturable cells and increased host cell metabolic burden following induction of

production21. Subsequently, we circumvented the former limitation by developing and optimising a scalable fed-batch process which reduced acetate accumulation and increased SELP yield to 4.3

 g L−1, the highest reported value for any PBP to date22. In the present study, we attempted to address the latter limitations identified and further increase SELP productivity. Our previous

studies have shown that ampicillin resistance as a selective marker for plasmid stabilisation during high cell density production of proteins is ineffective due to the rapid degradation of

ampicillin by the antibiotic resistance protein β-lactamase21. This ineffectiveness of ampicillin, in addition to the deprecation by regulatory authorities of its use in biotherapeutics and

biomaterials production due to safety concerns23,24,25, prompted us to investigate other plasmid stabilisation systems. Indeed, use of β-lactam antibiotics such as ampicillin poses safety

risks associated with their potential for causing serious hypersensitivity reactions in patients and for leading to the spread of antibiotic resistance traits to the environments25,26.

Furthermore, their use, and the necessity for additional purification and testing to ensure their absence in the final product leads to higher process costs. The antibiotic kanamycin is more

readily accepted25 but a recently developed antibiotic free system, the separate-component-stabilisation system (SCS)26,27, offers a means of avoiding the use of costly antibiotics and

potentially improving both plasmid segregational stability and product yield and safety. This post-segregational stabilisation system employs a toxin producing host which kills host cells

that have lost the plasmid and an anti-toxin producing expression vector which inactivates the toxin, thereby ensuring persistence of plasmid-containing cells only. In addition, as compared

to antibiotic resistance markers, SCS has an improved safety profile as it is a naturally occurring system innocuous to eukaryotic cells26. Furthermore, it is expected to impose a reduced

metabolic burden on host cells due to the small sizes of the toxin (100 amino acids) and anti-toxin (90 amino acids) as well as the regulated expression of these (toxin production only in

the absence of anti-toxin)25,26,27. In contrast, the relatively large antibiotic-resistance proteins (β-lactamase: 263 amino acids + 23 amino acid signal sequence; aminoglycoside

3′-phosphotransferase: 271 amino acids) are constitutively expressed from the pET expression vectors and indeed have already been shown to have a deleterious effect on host cells24,28,29. In

this study, ampicillin and kanamycin resistance markers, as well as the SCS system and a plasmid construct devoid of any antibiotic resistance marker were compared for the fed-batch

production of a SELP and the production process optimised for improved product yield. In addition, a detailed comparative characterisation of the processes and of the effects on SELP

productivity and host cell metabolism, physiology and integrity was carried out and allowed for a better understanding of the impact and operation of the plasmid stabilisation systems

examined. RESULTS Plasmid instability negatively impacts product yield and process economics and is a major concern in the industrial production of proteins. In our earlier studies

optimising the production of a novel SELP (SELP-59-A), a rapid reduction in the proportion of culturable cells containing plasmid was observed following induction of production21,22. In the

present study we attempted to investigate this further by comparing the use of three different plasmid stabilisation systems in the fed-batch production of SELP-59-A: ampicillin resistance

(AmpR), kanamycin resistance (KanR) and the Separate Component Stabilisation System (SCS + AmpR). In addition, we investigated the effect of removing the antibiotic resistance gene from the

SCS expression vector (SCS) to examine if the resultant reduced plasmid size and reduced metabolic burden would affect process performance. SCS AS A TOOL FOR IMPROVING SELP PRODUCTIVITY A

modified, previously developed fed-batch process with a shortened pre-induction phase (induction at a dry cell weight of 25 g L−1) and prolonged post-induction phase (8 h) was employed for

the high cell density production of SELP-59-A with each of the 4 constructs prepared. 5 ± 0.6 g L−1 purified SELP was obtained with both SCS constructs (SCS + AmpR and SCS) under the

conditions used, whereas 3.5 ± 0.5 g L−1 was obtained with the AmpR construct and 3.4 ± 0.5 g L−1 with the KanR construct. This represents a ~40% increase for the SCS system and clearly

demonstrates the effectiveness of this in increasing recombinant protein yield. COMPARING PROCESS PERFORMANCE For all four constructs examined, similar biomass production and glucose

accumulation profiles were observed and, with the exception of lactic acid, highly similar metabolic byproduct accumulation profiles were also noted (Fig. 1). Dry cell weight (DCW) increased

during fed-batch feeding and initially also following induction (for ~3 h) but then eventually decreased, probably resultant of the increased metabolic stress imposed on host cells. This is

believed to be due to a deviation of cell resources from biomass production to recombinant protein production and is commonly reported with _E. coli_ as an expression host21,22,30,31.

Glucose, malic acid, succinic acid, formic acid, acetic acid and ethanol were maintained at low concentrations (<1 g L−1) during the process but, as previously reported22, lactic acid

drastically increased following induction (Fig. 1b). Lactic acid concentrations up to approximately 1 to 1.5 g L−1 for cultures with the AmpR and KanR constructs were observed but use of the

SCS constructs resulted in higher concentrations, averaging around 3 g L−1. As previously discussed22, this increase in lactic acid production following induction is probably resultant of a

diversion of cell resources during SELP production. Therefore, the higher lactic acid levels observed with the SCS constructs are probably related to the higher SELP productivity with these

constructs and hence greater pathway deregulation. Finally, the similar results observed with both SCS constructs, in the presence and absence of the ampicillin selection marker gene,

indicate that the resistance marker has little effect on the host under the conditions used here. PLASMID STABILITY VERSUS HOST CELL CULTURABILITY For monitoring of plasmid segregational

stability, initially, the most commonly used method was employed in which the number of culturable cells on antibiotic-containing media is calculated as a percentage of that on

antibiotic-free media (Fig. 2a). Hence only the productions with the AmpR, KanR and SCS + AmpR vectors could be investigated. From Fig. 2a it can be seen that, as previously reported21,22,

use of the ampicillin selection vector resulted in a rapid reduction in the proportion of plasmid-containing culturable cells following induction. 100% of culturable cells contained plasmid

before induction and already at 6 hours post induction only plasmid free cells were detected under the conditions used. Similar results were observed with the KanR marker (Fig. 2a). However,

with the SCS system all culturable cells were found to contain plasmid under the conditions used, even after 8 hours of induction. This suggests higher plasmid content for the fermentations

with the SCS system. However, and in contrast to this, the comparative quantification of the intracellular plasmid content in the bioreactor by both agarose gel visualisation (Fig. 2b) and

quantitative PCR (qPCR, Fig. 2c) indicated no significant differences between the various constructs. For the latter (Fig. 2c), it can be seen that plasmid content increased during the first

~3 to 4 hours and then levelled off at the higher levels attained with all constructs and with no significant difference being observed. Similarly, for the agarose gel study, bands are

poorly detectable under the conditions used before induction, but plasmid content increases following induction to higher comparable levels with all constructs, thereby further demonstrating

that no significant differences in plasmid content were detected with the techniques used in this study. Figure 3 shows the results for the culturable cell counts with the AmpR, SCS + AmpR

and SCS constructs as well as the calculated number of plasmid-bearing and plasmid-free cells with the AmpR marker. No plasmid-free cells were observed for the SCS constructs but this is not

unexpected with the protocol used, as these, even if present in the bioreactor culture medium would be prevented from growing on the LB plate medium due to toxin production from the host

chromosome. Furthermore, while an initial increase in cell density was observed following induction in all cases (Fig. 1), in contrast, here (Fig. 3) it can be seen that a very rapid decline

in culturable cell numbers immediately occurs with the AmpR construct. The number of culturable plasmid-containing cells drastically decreased throughout the experiment but the total

(plasmid-free + plasmid-containing) culturable cell number eventually levelled off due to the growth of plasmid-free cells. With the SCS system, an initial increase during the first hour

following induction was indeed observed for the total cell count, which is 100% plasmid containing, but this was then also followed by a rapid decrease in cell numbers. These discrepancies,

taken together with Fig. 2b and c where similar plasmid content is noted, suggests that the culturable cell counts (Fig. 3) and related culturable cell plasmid stability measurements (Fig.

2a) used here are not a true measure of plasmid stability. They do not simply indicate, as originally suggested, increased plasmid content with the SCS construct, but are more a measure of

cell culturability or colony forming ability, indicating a more rapid loss of cell viability and culturability when using the AmpR construct. Indeed, in agreement with this, our flow

cytometry assessment of cell viability using propidium iodide (PI) as probe (Fig. 4) indicated a more rapid loss of membrane integrity for cells with the AmpR construct. Here, live cells

with intact membranes exclude the PI dye whereas it easily penetrates dead or damaged cells and interacts with cell DNA leading to diffuse red fluorescence when excited with blue light at

488 nm. It can be seen from Fig. 4 that the onset of the PI-DNA interaction and fluorescence occurs earlier for cultures with the AmpR construct than for both SCS constructs and hence

indicates a more rapid accumulation of compromised cells for the former. Cell morphology was also studied but no significant differences were observed with the various constructs (Fig. 5).

At the time of induction, the majority of cells show typical _E. coli_ size and shape, but with increasing induction time an increasing number of cells with ‘pinched’ and transparent

terminals as well as cell fragmentation and an increase in the proportion of elongated cells is seen under the conditions used. Such changes in cell structure are indicative of cell stress

and have been previously reported during recombinant protein production in _E. coli_32. MAXIMISING SELP-59-A PRODUCTIVITY Having shown that both SCS constructs studied allowed for similarly

improved SELP productivity, construct SCS was chosen for further studies to determine the maximum achievable SELP productivity due to the absence of the antibiotic resistance marker on its

backbone. This construct was used with the previously optimised fed-batch process wherein the DCW on induction was increased to 75 g L−1 (the limit achievable with the bioreactor system

used) but here, as a result of the improved post induction viability of cells with this construct, longer post induction times were investigated. From Fig. 6 it can be seen that following

induction DCW initially increased before levelling off and then decreasing. Glucose concentrations were maintained at low levels throughout the duration of the experiment but organic acids

increased, with in particular lactic acid, but also malic and formic acid increasing significantly. Furthermore, the concentration of acetic acid, and to a lesser extent ethanol, suddenly

increased 10 hours post-induction, which concomitant with a reduction of DCW is indicative of cell disruption. A strong increase in culture viscosity, probably due to a release of

chromosomal DNA, and the release of proteins to the extracellular environment as observed by SDS analysis supports this. Reduced SELP yields were hence observed with the 12 h post-induction

period (9.3 ± 2 g L−1) and the highest production was observed 8 hours post-induction (12.8 ± 2 g L−1), with lower amounts being obtained for the shorter 4 hour post induction time (6.8 ± 1 

g L−1). DISCUSSION In this study, it is shown that use of the SCS system for the fed-batch production of SELP-59-A in _E. coli_ significantly enhances productivity as compared to the use of

antibiotic selection markers. With the optimised process developed herein 12.8 g L−1 purified SELP was obtained and represents the highest reported SELP productivity to date, being 3-fold

higher than that obtained with our previously optimised fed-batch process22 and 150-fold higher than that reported by other groups20. Indeed, this SCS system offers many advantages for the

fed-batch production of recombinant proteins in _E. coli_. It not only improves product yield, but also improves the safety profile by eliminating the use of antibiotics and antibiotic

resistance markers and reduces costs by negating the need for antibiotic addition and supplementary purification and testing to ensure product safety. It is suitable for the GMP production

of proteins and biotherapeutics such as PBPs and its use here in the scalable fed-batch process demonstrates its potential in industrially relevant processes. Furthermore, its use in the

present study for the high level production of a novel SELP demonstrates the commercial viability of SELPs and PBPs in general and should allow for a more widespread acceptance of these. No

significant differences in process performance or host cell physiology were noted when the SCS system was used in the presence or absence of an antibiotic selection marker. Interestingly,

previous studies have indicated that constitutive expression of antibiotic resistance markers negatively affects host cells and in fact marker accumulation up to levels as high as 20% of

total cellular protein29 and even inclusion body formation have been reported23. This imposes a metabolic load on host cells and it has been shown that its elimination can improve process

performance, namely for plasmid production processes23. However, protein overproduction imposes a severe metabolic burden on host cells30,31, as was seen here for SELP overproduction, and it

is possible that the negative effects resultant from the β-lactamase are negligible as compared to the effects imposed by this overproduction33 and hence are masked by these. Our studies

investigating plasmid stability using the traditional approach of enumerating the number of plasmid-containing colony-forming cells as a proportion of the total number of culturable cells

indicated an apparent increased stability with the SCS system (Fig. 2a). Even after 8 hours induction, 100% of the colony-forming units were plasmid-bearing whereas no plasmid-bearing

culturable cells were detected 6 hours post induction with the AmpR system under the conditions used. This suggests a higher number of plasmid-containing cells and higher plasmid content for

the fermentations with the SCS system which could allow for the higher SELP productivities observed, yet, in contrast, our quantitative studies did not reveal evidence of increased plasmid

content. The comparative quantification of the intracellular plasmid content by both agarose gel visualisation (Fig. 2b) and qPCR (Fig. 2c) did not indicate significant differences between

the various constructs examined under the conditions used. With all constructs, plasmid content initially increased and then levelled off at similar higher levels. Such an initial increase

in plasmid content has in fact been previously reported34 and is believed to be due to the decreased cell division following induction being accompanied by continued plasmid replication and

hence a resultant higher copy number per cell. Also, while the equivalent plasmid content observed for all constructs (Fig. 2b and c) appears somewhat contradictory to the culturable cell

plasmid stability results (Fig. 2a), equal plasmid content under the conditions used may not be unexpected as the SCS system is a post-segregational killer system27,33,35,36. It is not a

partitioning system that obliges daughter cells to take up a copy of the plasmid during cell division, but rather it prevents the outgrowth and proliferation of plasmid-free cells by toxin

inactivation of the host cell DNA gyrase27,33,35,36. Thus, in the true sense of the term ‘plasmid stability’, which is a measure of the likelihood with which a plasmid is inherited by

daughter cells at cell division, the SCS system would not be expected to enable an enhancement. In the present study, identical fed-batch processes were used with all constructs and hence,

as was indeed observed here, the rate of formation of plasmid-free cells and thus also the plasmid content, could be expected to be similar in all cases. Indeed, such results are consistent

with a previous study where it was argued that postsegregational killing systems do not increase plasmid stability36. Thus, it can be concluded that, under the controlled fed-batch

production conditions of our study, with a reduced post-induction feeding rate, equal concentrations of plasmid were observed with all constructs and thereby indicates that something, other

than plasmid stabilisation, allowed for the increased SELP production obtained. In relation to the culturable-cells plasmid stability study, it must be noted that the SCS system prevents

outgrowth of plasmid-free cells but with the AmpR construct these can grow and indeed outcompete the slower growing plasmid-containing cells and hence reduce the proportion of these and lead

to the results observed (Fig. 2a). That is to say, the relative, but not the absolute level of plasmid-containing cells is reduced with AmpR. In addition, as discussed earlier, plasmid-free

cells for the SCS system, even if present in the bioreactor, would not be able to form visible colonies and would not be detected with the plating techniques used here for measuring plasmid

stability. Therefore, the culturable cell plasmid stability test most commonly used is inappropriate for determining plasmid content in this case, it is not a measure of the number of cells

containing plasmid or of the intracellular plasmid content, but a measure of the proportion of dividing culturable cells containing plasmid. Recombinant protein overexpression places a

severe metabolic burden on host cells and its debilitating effects are well known30,31. It drains resources such as energy, precursor metabolites and protein synthesizing machinery from host

cell metabolism and leads to metabolic imbalances, reduced growth rates and cell disruption and death. In the present study, this was manifested by a reduced biomass accumulation (Fig. 1),

loss of cell culturability (Fig. 3), loss of membrane integrity (Fig. 4), alteration in cell morphology (Fig. 5) and increased byproduct formation (Figs 1 and 6) as well as, eventually, cell

disruption (Fig. 6). Interestingly, while a rapid loss of cell culturability was seen with all constructs following induction (Fig. 3), this loss was more rapid with the AmpR construct, and

together with the higher rate of loss of membrane integrity (Fig. 4) indicates a reduced fitness of cells with this construct as compared to those with the SCS system. This apparent

stimulating effect of the SCS system on host cells may initially appear somewhat counterintuitive, as the increased SELP production of these would be expected to impact a greater metabolic

burden, and indeed the higher lactic acid production of these (Fig. 1) is reflective of an increased metabolic deregulation resultant of this higher SELP production. However, the SCS system

prevents growth of plasmid-free cells, whereas with the AmpR construct these can compete with and outgrow the plasmid-bearing cells for nutrients, energy and other resources27,30,37,38. This

competition could impose an additional stress on the host cells and, consequently, may induce the increased rate of loss of culturability and membrane integrity observed, as well as, most

importantly, the reduced SELP productivity with the AmpR system under the conditions used. Thus, hereby, it is suggested that with the controlled fed-batch conditions used here, the SCS

system does not enable significantly increased plasmid content as compared to with AmpR, but it is an improved cell fitness, due to the absence of competition between plasmid-bearing and

plasmid-free cells, that enables improved SELP productivity with this system. It can also be seen that plasmid content, in fact, increases following induction and that the principle limiting

factor for improved productivity is the metabolic burden imposed on the host cells as a result of the recombinant protein overexpression. Indeed, this is already well described in the

literature30,31,33 and a recent study took successful initial steps in addressing this for the high level production of a recombinant silk protein with a high glycine content by

metabolically engineering the host for an increased glycyl-tRNA pool39,40. SELP is also characterised by a highly repetitive sequence and hence a similar metabolic approach combined with our

scalable antibiotic free technique described here may aid in further increasing yields and in better enhancing the economic feasibility of this novel biopolymer. CONCLUSIONS Protein based

polymers are being explored as the next generation of biomaterials and a critical step in the strategic analysis of their viability is a demonstration of their cost effective production in a

format suitable and safe for use in clinical practice. In this study, a scalable, reproducible, industrially relevant production process has been developed for the high level production of

a novel SELP with total elimination of the use of antibiotics and antibiotic selection markers. It was shown that use of a post-segregational suicide system, SCS, for the fed-batch

production of SELP-59-A in _E. coli_ significantly enhanced productivity as compared to the use of antibiotic selection markers. Furthermore, an in-depth characterisation of the process

provided insights into the operation of the stabilisation systems and production process and it is suggested that an improved viability of host cells plays a role in the observed increased

productivity with SCS. METHODS SELP POLYMER SELP-59-A was used in this study, this consists of a nine times repeated copolymer unit composed of five repeats of the silk amino acid consensus

sequence (GAGAGS) and nine repeats of an elastin mimetic sequence (VPAVG)21. VECTOR CONSTRUCTS All expression vectors used are based on the pET expression vector system (Novagen) and all

vector constructs prepared here were confirmed by restriction digestion and agarose gel analyses. SELP-59-A/PET25BAMPR The gene for SELP-59-A had already been inserted in a modified

pET25b(+)vector (Novagen) for expression in _E. coli_ BL21(DE3)12, this vector contains the ampicillin resistance selective marker gene encoding β-lactamase. SELP-59-A/PET29AKANR For the

kanamycin resistance marker (neomycin phosphotransferase II), the expression vector pET29a(+) (Novagen) was used. The SELP-59-A gene was excised from SELP-59-A/pET25bAmpR by digestion with

_Nde_I and _Blp_I and ligated with T4 DNA ligase into similarly digested pET29a(+). Plasmid constructs were transformed to _E. coli_ BL21(DE3) for expression. SELP-59-A/PSTABY1.2SCSAMPR For

the separate-component-stabilisation system (SCS), the expression vector pStaby1.2 (Delphi Genetics) was used. In addition to SCS, this vector also carries the ampicillin resistance marker,

it is a variant of pET21a(+) in which the gene for the antitoxin ccdA has been inserted. The SELP-59-A gene was excised from SELP-59-A/pET25bAmpR by digestion with _Nde_I and _Blp_I and

ligated with T4 DNA ligase into similarly digested pStaby1.2. Plasmid constructs were first transformed to the cloning host _E. coli_ CYS21 (Delphi Genetics) before transformation to the

expression host _E. coli_ SE1 (Delphi Genetics), this is a variant of _E. coli_ BL21(DE3) with a chromosomal copy of the gene for the ccdB toxin. SELP-59-A/PSTABY1.2SCS The β-lactamase gene

and promotor were removed from SELP-59-A/pStaby1.2SCSAmpR by digestion with _Ssp_I and _Eam_1105I, purified fragments were converted to blunt ended fragments by treatment with Accuzyme mix

(Bioline) for 30 mins at 72 °C and re-circularised with T4 DNA ligase. Plasmid constructs were transformed to _E. coli_ SE1 (Delphi Genetics) for expression. FED-BATCH PRODUCTION Fed-batch

fermentations were performed as previously described22 in a BioFlo 110 Modular Benchtop 3 L fermentor (New Brunswick Scientific, NBS). The whole process involved two precultures followed by

a production process composed of three phases (batch, fed-batch and induction) in the minimal medium MMLBM as described by Collins _et al_.22. The conditions used were as previously

detailed22, namely: 37 ± 1 °C, pH 6.8 ± 0.1 (25% w/w NH4OH and 3 M H3PO4), minimum dissolved oxygen concentration = 25% (batch phase) and 35% (fed-batch phase) with control by cascading to

agitation (200–1100 rpm) and O2 feeding (only during the fed-batch phase), gas (air, air + O2) flow rate = 5 L min−1 and antifoam Y-30 emulsion for foaming control (Sigma). 200 μg/mL

ampicillin was used for all precultures and production cultures with the AmpR constructs and 100 μg/mL kanamycin was used for the KanR construct while no antibiotic was included for the

_SELP-59-A/pStaby1.2SCS_ construct. All fed-batch studies were repeated at least three times. For the comparative study of fed-batch productions with the four different vector constructs, a

pre-induction growth rate of 0.5 h−1, post-induction growth rate of 0.1 h−1 and induction at a dry cell weight of 25 g L−1 with 3 mM IPTG for 8 hours was used. Here, a higher IPTG

concentration (3 mM IPTG) was used than that previously recommended (1 mM IPTG21) as this has been shown to have a greater negative effect on the proportion of plasmid containing culturable

cells while not affecting the final product yield21. Maximum achievable SELP-59-A productivity was determined for the construct identified as enabling highest plasmid stability by use of the

previously optimised fed batch production process22 wherein a pre-induction growth rate of 0.4 h−1, post-induction growth rate of 0.1 h−1 and induction at a dry cell weight of 75 g L−1 with

1 mM IPTG was used. The post induction period was optimised by examining productivities and process parameters after 4, 8 and 12 hours post induction incubation. PROCESS MONITORING Process

parameters such as glucose, ethanol, organic acids (citric, tartaric, malic, succinic, lactic, acetic and formic), phosphate, nitrogen and biomass concentrations were analysed and compared

as previously described22. SELP PRODUCTION QUANTIFICATION SELP production levels for the various constructs were determined by weight measurements of purified product as previously

described12,22. A previously developed non-chromatographic approach was used for purification12. This involved cell disruption by sonication, overnight acid treatment at pH 3.5 to denature

contaminants, centrifugation and SELP precipitation with 20% ammonium sulphate. Following centrifugation, resuspension and dialysis in distilled water, the purified SELP was then lyophilied

and weighed. CULTURABLE CELL COUNT Samples were taken at the time of induction and every hour thereafter, serially diluted in sterile phosphate buffered saline (PBS: 8 g L−1 NaCl, 0.2 g L−1

KCl, 1.44 g L−1 Na2HPO4, 0.24 g L−1 KH2PO4, pH 7.4) and 25 μL of the 10−3–10−7 dilutions spread plated in triplicate on LB plates (10 g L−1 bacto tryptone, 5 g L−1 yeast extract, 5 g L−1

NaCl, 18 g L−1 agar, pH 7) and incubated overnight at 37 °C. CULTURABLE CELL PLASMID STABILITY 100 colony forming units of the culturable cell count study were repicked to LB + ampicillin

(200 μg mL ampicillin) plates and incubated overnight at 37 °C before enumeration. AGAROSE GEL ELECTROPHORESIS FOR PLASMID QUANTIFICATION Plasmid content was evaluated at the time of

induction and every two hours thereafter. The OD600nm of culture samples was measured and cell pellets washed twice in PBS before resuspension and dilution in TE buffer (50 mM Tris, 1 mM

EDTA, pH 8) to an OD600nm of 2. This was followed by chemical lysis and chromosomal DNA removal with the lysis and precipitation reagents (buffers A1, A2 and A3) of the NucleoSpin Plasmid

Kit (Macherey-Nagel) as described by the manufacturer. 400 μL of plasmid extract was concentrated by precipitation with 50% isopropanol overnight at −20 °C, resuspended in 100 μL water and

20 μL loaded on midori green stained 1% agarose gels for visualization and band intensity comparison. QPCR FOR RELATIVE PLASMID QUANTIFICATION Quantitative PCR (qPCR) was used to monitor the

relative plasmid content during the fed-batch productions. The OD600nm of culture samples was measured and cell pellets washed twice in PBS before resuspension and dilution in TE buffer to

an OD600nm of 1. Following treatment of 100 μL sample with 50 μg/mL RNase A, cells were disrupted by addition of 2% SDS and heating at 75 °C for 5 minutes. Supernatants were diluted 104-fold

in water before qPCR analysis. qPCR reactions were performed in duplicate for each sample on a CFX96 Touch™ Real-Time PCR detection system (Bio-rad) with Sso7d fusion polymerase and

EvaGreen® dye (SsoFast™ EVAGreen® Supermix, Bio-Rad). Data were analysed with the CFX Manager TMSoftware v3.1 (Bio-Rad). PCR conditions used were: denaturation at 95 °C for 3 minutes

followed by 40 cycles of denaturation at 95 °C for 10 s and annealing/extension for 10 s at 63 °C (plasmid) or 60 °C (host chromosome). Amplification specificity and absence of reaction

contaminants were confirmed by analysis of melting curves following heating of amplification products from 60 to 95 °C. For qPCR analysis a variation of the protocol described by Lee _et

al_. 200641 was used in which both plasmid and host chromosome content are monitored so as to eliminate sample preparation and processing variations. Primers were designed

(GATCCGGCTGCTAACAAAGC; TTAGAGGCCCCAAGGGGTTA) to amplify an 89 bp fragment present on all four vector constructs studied. 0.25 μM primers and an annealing/extension temperature of 63 °C with

an amplification efficiency of 102.4% and R2 of 0.987 were used. For monitoring of host chromosome content, 0.25 μM primers (ACAAAACGCATATCGACCAGC; GCGATCCTTAACTTTGGTACGC) and an

annealing/extension temperature of 60 °C were employed to amplify an 86 bp fragment present on the _E. coli_ chromosomal d-1-deoxyxylulose 5-phosphate synthase (dxs) sequence with an

amplification efficiency of 103.3% and R2 of 0.994. Relative quantification was performed by the ΔΔCT (ΔΔ threshold cycle) method41,42 and results are expressed as a fold ratio of the

normalized plasmid amount. FLOW CYTOMETRY Propidium iodide was used as a probe of membrane integrity with the flow cytometry analysis of samples collected at induction and every two hours

thereafter. Culture samples were diluted 102-fold in PBS and stained with 1 μg/mL propidium iodide (Sigma) for 10 minutes in the dark at room temperature. Analysis was performed with an

EPICS® XL™ flow cytometer (Beckman Coulter) at a flow rate of 200–500 events per second. The cell population was gated in a histogram of Side Scatter (SS) versus Forward Scatter (fs) and

monoparametric detection of propidium iodide fluorescence was performed using FL-3 (488/620 nm). Twenty thousand cells were analysed per sample. SCANNING ELECTRON MICROSCOPY 10-fold

dilutions of culture samples collected at the time of induction and at 2 hourly intervals until the end of fermentation were analysed by scanning electron microscopy (SEM). Samples were

fixed to plastic disc supports by treatment with 2.5% glutaraldehyde in PBS for 1 hour and dehydrated by successive 30 minute immersions in ethanol solutions of increasing concentration (55,

70, 80, 90, 95 and 100% v/v ethanol in water). Following drying at room temperature overnight, samples were coated with a thin gold layer using a Polaron model SC502 sputter coater and

visualised on a NanoSEM-FEI Nova 200 scanning electron microscope (Leica Cambridge). ADDITIONAL INFORMATION HOW TO CITE THIS ARTICLE: Barroca, M. _et al_. Antibiotic free selection for the

high level biosynthesis of a silk-elastin-like protein. _Sci. Rep._ 6, 39329; doi: 10.1038/srep39329 (2016). PUBLISHER’S NOTE: Springer Nature remains neutral with regard to jurisdictional

claims in published maps and institutional affiliations. REFERENCES * Yigit, S., Dinjaski, N. & Kaplan, D. L. Fibrous proteins: At the crossroads of genetic engineering and

biotechnological applications. Biotechnol. Bioeng. 113, 913–929, doi: 10.1002/bit.25820 (2016). Article  CAS  PubMed  Google Scholar  * Dinjaski, N. & Kaplan, D. L. Recombinant protein

blends: Silk beyond natural design. Curr. Opin. Biotechnol. 39, 1–7, doi: 10.1016/j.copbio.2015.11.002 (2016). Article  CAS  PubMed  Google Scholar  * Chow, D., Nunalee, M. L., Lim, D. W.,

Simnick, A. J. & Chilkoti, A. Peptide-based biopolymers in biomedicine and biotechnology. Mater. Sci. Eng. R Rep. 62, 125–155, doi: 10.1016/j.mser.2008.04.004 (2008). Article  CAS 

PubMed  PubMed Central  Google Scholar  * Hu, X. et al. Stability of silk and collagen protein materials in space. Sci. Rep. 3, 3428, doi: 10.1038/srep03428 (2013). Article  PubMed  PubMed

Central  Google Scholar  * Rodriguez-Cabello, J. C., Arias, F. J., Rodrigo, M. A. & Girotti, A. Elastin-like polypeptides in drug delivery. Adv. Drug Deliv. Rev. 97, 85–100, doi:

10.1016/j.addr.2015.12.007 (2016). Article  CAS  PubMed  Google Scholar  * Hazra, S. et al. Non-mulberry silk fibroin biomaterial for corneal regeneration. Sci. Rep. 6, 21840, doi:

10.1038/srep21840 (2016). Article  ADS  CAS  PubMed  PubMed Central  Google Scholar  * Poursaid, A. et al. _In situ_ gelling silk-elastinlike protein polymer for transarterial

chemoembolization. Biomaterials 57, 142–152, doi: 10.1016/j.biomaterials.2015.04.015 (2015). Article  CAS  PubMed  PubMed Central  Google Scholar  * Saxena, R. & Nanjan, M. J.

Elastin-like polypeptides and their applications in anticancer drug delivery systems: A review. Drug Deliv. 22, 156–167, doi: 10.3109/10717544.2013.853210 (2015). Article  CAS  PubMed 

Google Scholar  * Kujala, S., Mannila, A., Karvonen, L., Kieu, K. & Sun, Z. Natural silk as a photonics component: A study on its light guiding and nonlinear optical properties. Sci.

Rep. 6, 22358, doi: 10.1038/srep22358 (2016). Article  ADS  CAS  PubMed  PubMed Central  Google Scholar  * MacEwan, S. R. & Chilkoti, A. Applications of elastin-like polypeptides in drug

delivery. J. Control. Release 190, 314–330, doi: 10.1016/j.jconrel.2014.06.028 (2014). Article  CAS  PubMed  PubMed Central  Google Scholar  * Silva, R., Fabry, B. & Boccaccini, A. R.

Fibrous protein-based hydrogels for cell encapsulation. Biomaterials 35, 6727–6738, doi: 10.1016/j.biomaterials.2014.04.078 (2014). Article  CAS  PubMed  Google Scholar  * Machado, R. et al.

High level expression and facile purification of recombinant silk-elastin-like polymers in auto induction shake flask cultures. AMB Express 3, 11, doi: 10.1186/2191-0855-3-11 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar  * Machado, R. et al. Electrospun silk-elastin-like fibre mats for tissue engineering applications. Biomed. Mater. 8, 065009, doi:

10.1088/1748-6041/8/6/065009 (2013). Article  ADS  CAS  PubMed  Google Scholar  * Machado, R. et al. Exploring the properties of genetically engineered silk-elastin-like protein films.

Macromol. Biosci. 15, 1698–1709, doi: 10.1002/mabi.201500132 (2015). Article  CAS  PubMed  Google Scholar  * Huang, W., Rollett, A. & Kaplan, D. L. Silk-elastin-like protein biomaterials

for the controlled delivery of therapeutics. Expert Opin. Drug Deliv. 12, 779–791, doi: 10.1517/17425247.2015.989830 (2015). Article  CAS  PubMed  Google Scholar  * Chow, D. C., Dreher, M.

R., Trabbic-Carlson, K. & Chilkoti, A. Ultra-high expression of a thermally responsive recombinant fusion protein in _E. Coli_. Biotechnol. Prog. 22, 638–646, doi: 10.1021/bp0503742

(2006). Article  CAS  PubMed  PubMed Central  Google Scholar  * Haider, M., Hatefi, A. & Ghandehari, H. Recombinant polymers for cancer gene therapy: A minireview. J. Control. Release

109, 108–119, doi: 10.1016/j.jconrel.2005.09.018 (2005). Article  CAS  PubMed  Google Scholar  * Shi, J., Lua, S., Du, N., Liu, X. & Song, J. Identification, recombinant production and

structural characterization of four silk proteins from the asiatic honeybee _Apis cerana_. Biomaterials 29, 2820–2828, doi: 10.1016/j.biomaterials.2008.03.020 (2008). Article  CAS  PubMed 

Google Scholar  * Weisman, S. et al. Honeybee silk: Recombinant protein production, assembly and fiber spinning. Biomaterials 31, 2695–2700, doi: 10.1016/j.biomaterials.2009.12.021 (2010).

Article  CAS  PubMed  Google Scholar  * Xia, X. X., Xu, Q., Hu, X., Qin, G. & Kaplan, D. L. Tunable self-assembly of genetically engineered silk-elastin-like protein polymers.

Biomacromolecules 12, 3844–3850, doi: 10.1021/bm201165h (2011). Article  CAS  PubMed  PubMed Central  Google Scholar  * Collins, T. et al. Batch production of a silk-elastin-like protein in

_E. Coli_ BL21(DE3): Key parameters for optimisation. Microb. Cell Fact. 12, 21, doi: 10.1186/1475-2859-12-21 (2013). Article  CAS  PubMed  PubMed Central  Google Scholar  * Collins, T. et

al. High level biosynthesis of a silk-elastin-like protein in _E. Coli_. Biomacromolecules 15, 2701–2708, doi: 10.1021/bm5005564 (2014). Article  CAS  PubMed  Google Scholar  * Mairhofer, J.

et al. Marker-free plasmids for gene therapeutic applications–lack of antibiotic resistance gene substantially improves the manufacturing process. J. Biotechnol. 146, 130–137, doi:

10.1016/j.jbiotec.2010.01.025 (2010). Article  CAS  PubMed  Google Scholar  * Peubez, I. et al. Antibiotic-free selection in _E. Coli:_ New considerations for optimal design and improved

production. Microb. Cell Fact. 9, 65, doi: 10.1186/1475-2859-9-65 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Vandermeulen, G., Marie, C., Scherman, D. & Preat, V.

New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials. Mol. Ther. 19, 1942–1949, doi: 10.1038/mt.2011.182 (2011). Article  CAS  PubMed  PubMed

Central  Google Scholar  * Reschner, A. et al. Use of staby(®) technology for development and production of DNA vaccines free of antibiotic resistance gene. Hum. Vaccin. Immunother. 9,

2203–2210, doi: 10.4161/hv.25086 (2013). Article  CAS  PubMed  PubMed Central  Google Scholar  * Szpirer, C. Y. & Milinkovitch, M. C. Separate-component-stabilization system for protein

and DNA production without the use of antibiotics. Biotechniques 38, 775–781 (2005). Article  CAS  PubMed  Google Scholar  * Oliveira, P. H. & Mairhofer, J. Marker-free plasmids for

biotechnological applications - implications and perspectives. Trends Biotechnol. 31, 539–547, doi: 10.1016/j.tibtech.2013.06.001 (2013). Article  CAS  PubMed  Google Scholar  * Cunningham,

D. S., Koepsel, R. R., Ataai, M. M. & Domach, M. M. Factors affecting plasmid production in _Escherichia coli_ from a resource allocation standpoint. Microb. Cell Fact. 8, 27, doi:

10.1186/1475-2859-8-27 (2009). Article  CAS  PubMed  PubMed Central  Google Scholar  * Glick, B. R. Metabolic load and heterologous gene expression. Biotechnol. Adv. 13, 247–261 (1995).

Article  CAS  PubMed  Google Scholar  * Carneiro, S., Ferreira, E. C. & Rocha, I. Metabolic responses to recombinant bioprocesses in _Escherichia coli_. J. Biotechnol. 164, 396–408, doi:

10.1016/j.jbiotec.2012.08.026 (2013). Article  CAS  PubMed  Google Scholar  * Kyle, S., James, K. A. & McPherson, M. J. Recombinant production of the therapeutic peptide lunasin.

Microb. Cell Fact. 11, 28, doi: 10.1186/1475-2859-11-28 (2012). Article  CAS  PubMed  PubMed Central  Google Scholar  * Andersson, L., Yang, S., Neubauer, P. & Enfors, S. O. Impact of

plasmid presence and induction on cellular responses in fed batch cultures of _Escherichia coli_. J. Biotechnol. 46, 255–263 (1996). Article  CAS  PubMed  Google Scholar  * Soriano, E.,

Borth, N., Katinger, H. & Mattanovich, D. Flow cytometric analysis of metabolic stress effects due to recombinant plasmids and proteins in _Escherichia coli_ production strains. Metab.

Eng. 1, 270–274, doi: 10.1006/mben.1999.0128 (1999). Article  CAS  PubMed  Google Scholar  * Hayes, F. Toxins-antitoxins: Plasmid maintenance, programmed cell death, and cell cycle arrest.

Science 301, 1496–1499, doi: 10.1126/science.1088157 (2003). Article  ADS  CAS  PubMed  Google Scholar  * Cooper, T. F. & Heinemann, J. A. Postsegregational killing does not increase

plasmid stability but acts to mediate the exclusion of competing plasmids. Proc. Natl. Acad. Sci. USA 97, 12643–12648, doi: 10.1073/pnas.220077897 (2000). Article  ADS  CAS  PubMed  PubMed

Central  Google Scholar  * Bhattacharyya, J., Smith, H. L. & Pal, S. Allelopathy of plasmid-bearing and plasmid-free organisms competing for two complementary resources in a chemostat.

J. Biol. Dyn. 6, 628–644, doi: 10.1080/17513758.2012.668565 (2012). Article  PubMed  Google Scholar  * Smith, M. A. & Bidochka, M. J. Bacterial fitness and plasmid loss: The importance

of culture conditions and plasmid size. Can. J. Microbiol. 44, 351–355 (1998). Article  CAS  PubMed  Google Scholar  * Yang, Y.-X., Qian, Z.-G., Zhong, J.-J. & Xia, X.-X.

Hyper-production of large proteins of spider dragline silk MaSp2 by _Escherichia coli_ via synthetic biology approach. Process Biochem. 51, 484–490, doi: 10.1016/j.procbio.2016.01.006

(2016). Article  CAS  Google Scholar  * Xia, X. X. et al. Native-sized recombinant spider silk protein produced in metabolically engineered _Eescherichia coli_ results in a strong fiber.

Proc. Natl. Acad. Sci. USA 107, 14059–14063, doi: 10.1073/pnas.1003366107 (2010). Article  ADS  PubMed  PubMed Central  Google Scholar  * Lee, C., Kim, J., Shin, S. G. & Hwang, S.

Absolute and relative qPCR quantification of plasmid copy number in _Escherichia coli_. J. Biotechnol. 123, 273–280, doi: 10.1016/j.jbiotec.2005.11.014 (2006). Article  CAS  PubMed  Google

Scholar  * Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402–408, doi:

10.1006/meth.2001.1262 (2001). Article  CAS  PubMed  Google Scholar  Download references ACKNOWLEDGEMENTS This work was financed by the European Commission via the 7th Framework Programme

Project EcoPlast (FP7-NMP-2009-SME-3), by national funds from the FCT through EXPL/BBB-BIO/1772/2013-FCOMP-01-0124-FEDER-041595, the strategic programme UID/BIA/04050/2013

(POCI-01-0145-FEDER-007569) and a fellowship to SRC (SFRH/BPD/89980/2012), as well as from ERDF through COMPETE2020 - Programa Operacional Competitividade e Internacionalização (POCI). T.C.

is supported by the FCT, the European Social Fund, the Programa Operacional Potencial Humano and the Investigador FCT Programme (IF/01635/2014). All the technical staff at the CBMA are

thanked for their skilful technical assistance. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Biology, Centre of Molecular and Environmental Biology (CBMA), University of

Minho, Campus de Gualtar, 4710-057, Braga, Portugal Mário Barroca, Paulo Rodrigues, Susana R. Chaves, Raul Machado, Margarida Casal & Tony Collins * Biosystems and Integrative Sciences

Institute (BioISI), Plant Functional Biology Centre, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal Rómulo Sobral & M. Manuela R. Costa Authors * Mário Barroca View

author publications You can also search for this author inPubMed Google Scholar * Paulo Rodrigues View author publications You can also search for this author inPubMed Google Scholar *

Rómulo Sobral View author publications You can also search for this author inPubMed Google Scholar * M. Manuela R. Costa View author publications You can also search for this author inPubMed

 Google Scholar * Susana R. Chaves View author publications You can also search for this author inPubMed Google Scholar * Raul Machado View author publications You can also search for this

author inPubMed Google Scholar * Margarida Casal View author publications You can also search for this author inPubMed Google Scholar * Tony Collins View author publications You can also

search for this author inPubMed Google Scholar CONTRIBUTIONS T.C. and M.C. conceived the study. M.B., P.R. and T.C. designed the study and carried out the fed-batch productions and process

analyses. P.R., R.S. and M.M.R.C. effectuated the qPCR studies and S.R.C. carried out the flow cytometry analysis. R.M. and M.C. provided the SELP-59-A construct. All authors read and

approved the manuscript. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing financial interests. RIGHTS AND PERMISSIONS This work is licensed under a Creative Commons

Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the

credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of

this license, visit http://creativecommons.org/licenses/by/4.0/ Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Barroca, M., Rodrigues, P., Sobral, R. _et al._ Antibiotic free

selection for the high level biosynthesis of a silk-elastin-like protein. _Sci Rep_ 6, 39329 (2016). https://doi.org/10.1038/srep39329 Download citation * Received: 26 July 2016 * Accepted:

14 October 2016 * Published: 16 December 2016 * DOI: https://doi.org/10.1038/srep39329 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get

shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative